Patients who are prescribed immunoglobulin therapy often encounter two terms: IVIG and SCIG.
Both treatments provide immunoglobulin, or antibodies collected from donated human plasma, but the way the medication is administered can be very different.
IVIG stands for intravenous immunoglobulin. It is infused directly into a vein.
SCIG stands for subcutaneous immunoglobulin. It is administered into the fatty tissue underneath the skin.
That difference affects treatment frequency, infusion time, where therapy may be provided, side effects, patient independence, and the overall treatment experience.
The U.S. Food and Drug Administration lists multiple licensed intravenous and subcutaneous immune globulin products, and individual products have different approved indications and prescribing requirements.
At Mercy Infusion, we help patients who have been prescribed immunoglobulin therapy coordinate insurance benefits, prior authorization, medication access, education, and the appropriate treatment setting.
“IVIG and SCIG are both important treatment options, but they fit into a patient’s life very differently. The right choice depends on the diagnosis, physician’s treatment plan, clinical needs, insurance coverage, and what is practical for the individual patient.”
— April Cable, Senior Director of Operations
Have You Been Prescribed Immunoglobulin Therapy?
Mercy Infusion can help coordinate your physician’s prescription, insurance benefits, authorization requirements, medication, and treatment setting.
Learn About IVIG Therapy
Learn About SCIG Therapy
Call 833-594-0124
What Is IVIG?
IVIG delivers immunoglobulin directly into the bloodstream through an intravenous catheter.
A physician determines the appropriate product, dose, frequency, infusion rate, and treatment setting.
IVIG may be used for certain:
- Primary immunodeficiencies
- Neurologic disorders
- Autoimmune conditions
- Blood disorders
- Other physician-diagnosed conditions
Patients can read our more detailed guide, What Is IVIG Therapy?, at /what-is-ivig-therapy/.
Because the medication goes directly into a vein, IVIG often delivers a relatively large dose during each treatment session. Treatments may occur every few weeks, although schedules vary considerably based on the diagnosis and prescription.
What Is SCIG?
SCIG delivers immunoglobulin into tissue underneath the skin rather than directly into a vein.
Depending on the product and treatment plan, medication may be administered through one or more small infusion sites, commonly in areas such as the abdomen or thighs.
FDA-approved SCIG products include Cutaquig, Cuvitru, Hizentra, HyQvia, Xembify, and others. Approved uses vary by product.
SCIG is frequently used as immunoglobulin replacement therapy for patients with certain primary immunodeficiencies. Selected SCIG products also have other indications. For example, HYQVIA is approved for primary immunodeficiency and for maintenance therapy in adults with CIDP.
IVIG vs. SCIG at a Glance
| Consideration | IVIG | SCIG |
| Administration | Into a vein | Under the skin |
| Typical dose pattern | Larger doses less frequently | Smaller doses more frequently |
| Treatment location | Home or clinical setting | Often at home |
| Venous access | Required | Not required |
| Nursing | Often nurse administered | Some patients may self-administer after training |
| Frequency | Often every few weeks | Often weekly or more frequently depending on product |
| Systemic reactions | Can occur | Generally different reaction profile |
| Local-site reactions | Less prominent | More common around infusion sites |
| Patient independence | Lower for nurse-administered IVIG | Potentially greater after training |
This comparison is general. Individual products and treatment plans differ.
How Often Are IVIG and SCIG Given?
One of the most noticeable differences is frequency.
IVIG usually delivers a larger dose during a longer infusion and may be scheduled every several weeks for patients receiving maintenance therapy.
SCIG divides the immunoglobulin into smaller doses administered more frequently.
Depending on the specific product, SCIG may be given:
- Several times per week
- Weekly
- Every other week
- At another physician-directed interval
Some facilitated SCIG products allow larger volumes and longer intervals than conventional SCIG.
The physician determines the schedule based on the medication, diagnosis, weight, treatment goals, clinical response, and product labeling.
Where Is Treatment Given?
IVIG
IVIG may be administered:
- At home
- In an ambulatory infusion suite
- In a physician’s office
- In a hospital outpatient department
- In an inpatient setting when medically necessary
Mercy Infusion provides eligible patients with both /home-infusion/ and /infusion-suite/ options.
SCIG
SCIG is frequently designed around home administration.
Initially, a nurse or other qualified healthcare professional may provide education and training. Certain patients may eventually administer their own therapy after the clinical team determines that self-administration is appropriate.
Patients should never begin self-administration without appropriate physician direction and training.
What Are the Lifestyle Differences?
IVIG May Appeal to Patients Who Prefer:
- Less frequent treatment
- A nurse administering therapy
- Fewer treatment days each month
- A clinical environment
- Not having to manage frequent home infusions
The tradeoff is that an individual IVIG session can last several hours.
SCIG May Appeal to Patients Who Prefer:
- No regular IV placement
- Greater control over scheduling
- Home-based treatment
- More independence
- Smaller, more frequent doses
The tradeoff is that patients may need to incorporate treatment into their routine more often.
There is no universally “better” approach.
The question is which treatment is medically appropriate and works best within the physician-directed care plan.
Are the Side Effects Different?
Yes.
Both IVIG and SCIG can cause side effects, and all immune globulin products carry product-specific warnings and precautions.
IVIG-Related Symptoms May Include:
- Headache
- Fatigue
- Chills
- Nausea
- Dizziness
- Flu-like symptoms
- Infusion-related reactions
Serious but less common reactions can include blood clots, kidney problems, severe allergic reactions, hemolysis, and aseptic meningitis.
SCIG-Related Symptoms
Because SCIG is delivered into tissue underneath the skin, local reactions are common.
These may include:
- Redness
- Swelling
- Tenderness
- Itching
- Warmth
- Discomfort around the infusion site
Systemic reactions can also occur.
The FDA notes that hypersensitivity reactions are a known risk with both intravenous and subcutaneous immune globulin products.
Patients should discuss the risks of their specific product with their physician and pharmacist.
Does SCIG Eliminate the Need for a Nurse?
Not necessarily.
Some patients eventually self-administer SCIG, but the process usually begins with clinical education.
Patients may need to learn:
- How to prepare medication
- How to select infusion sites
- How to insert the necessary equipment
- How to operate an infusion pump when required
- Proper storage
- Infection-control practices
- How to recognize reactions
- When to call the healthcare team
Some patients prefer independence. Others are more comfortable having a nurse administer treatment.
Can Someone Switch From IVIG to SCIG?
For certain patients, yes.
A physician may consider a transition because of:
- Difficulty obtaining IV access
- Lifestyle preferences
- Desire for home treatment
- Infusion-related symptoms
- Scheduling considerations
- Insurance requirements
- Changes in the treatment plan
However, IVIG and SCIG are not automatically interchangeable.
The physician must determine whether an appropriate SCIG product is indicated for the patient’s condition and calculate the correct dose and schedule.
Does Insurance Cover Both?
Coverage varies.
The insurer may consider:
- Diagnosis
- Product
- Medical necessity
- Prior authorization
- Previous treatments
- Preferred medication
- Pharmacy network
- Treatment setting
- Dose and frequency
A health plan may approve IVIG but require additional review before covering SCIG, or vice versa.
Mercy Infusion helps patients navigate the /how-it-works/ process, including benefits verification and prior authorization.
Need Help With Insurance or Cost?
Our team can review insurance requirements and explore /copay-assistance/ and financial-support resources when available.
Explore Copay Assistance
Call 833-594-0124
Financial assistance and coverage cannot be guaranteed.
Frequently Asked Questions
Is SCIG the same medication as IVIG?
Both provide immunoglobulin antibodies derived from human plasma, but products, concentrations, formulations, routes, doses, and approved indications differ.
Is SCIG better than IVIG?
Not universally. The appropriate therapy depends on the diagnosis, medical needs, product indication, physician recommendation, insurance, and patient circumstances.
Does SCIG require an IV?
No. SCIG is administered into tissue under the skin.
Can IVIG be administered at home?
Yes, eligible patients may receive physician-prescribed IVIG through /home-infusion/.
Can patients administer SCIG themselves?
Some patients may self-administer after receiving appropriate training and physician approval.
Which treatment is more frequent?
SCIG is generally administered more frequently, while IVIG often provides a larger dose at longer intervals.
Is SCIG approved for CIDP?
Certain products are. HYQVIA is currently FDA-approved for maintenance therapy in adults with CIDP, and Hizentra has an FDA-approved maintenance indication for adults with CIDP.
Can Mercy Infusion help me switch therapies?
Mercy can coordinate a physician-directed change after receiving the appropriate prescription and clinical information.
Choosing Between IVIG and SCIG
IVIG and SCIG have the same broad goal of providing immunoglobulin, but the treatment experience differs considerably.
For some patients, receiving a larger IV dose every few weeks is more convenient.
For others, smaller home-based SCIG doses provide greater independence.
The decision should ultimately be made with the treating physician based on diagnosis, clinical needs, medication availability, insurance requirements, and patient preferences.
Speak With Mercy Infusion
If you have been prescribed IVIG or SCIG, Mercy Infusion can help coordinate your prescription, insurance benefits, prior authorization, medication access, education, and treatment.
Learn About IVIG
Learn About SCIG
Call 833-594-0124
About the Author
April Cable, Senior Director of Operations
April Cable has more than 35 years of experience in specialty pharmacy billing, reimbursement, operations, and patient access. She helps patients navigate insurance benefits, prior authorization, financial-support programs, and specialty medication onboarding while coordinating with physicians, insurers, pharmacists, and clinical teams.
This article is for general educational purposes and does not determine which immunoglobulin treatment is appropriate for an individual patient. Treatment decisions must be made by the prescribing physician.
